Beta Bionics Inc
Beta Bionics Inc (BBNX) Straddle
BBNX straddle scan found 14 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 66.8%.
Read more
Trading a BBNX straddle lets you take a pure volatility position on Beta Bionics Inc without committing to a direction. Beta Bionics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate BBNX straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on BBNX profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Beta Bionics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the BBNX straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes.
It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is based in Irvine, California.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the BBNX straddle is the cleanest expression of that view. Our scanner prices every BBNX straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a BBNX straddle into a catalyst or short a BBNX straddle to harvest decay, the options straddle setups that matter are all in one place.
| Apr 16, 2027 | 30.00 | $12.73 | 207 | — | 66.8% | $42.73 | $17.28 | 0 |
| Apr 16, 2027 | 25.00 | $11.00 | 207 | — | 61.6% | $36.00 | $14.00 | 0 |
| Apr 16, 2027 | 22.50 | $10.40 | 207 | — | 57.7% | $32.90 | $12.10 | 0 |
| Jan 15, 2027 | 22.50 | $8.58 | 116 | — | 54.2% | $31.08 | $13.93 | 0 |
| Apr 16, 2027 | 20.00 | $9.80 | 207 | — | 53.7% | $29.80 | $10.20 | 0 |
| Nov 20, 2026 | 25.00 | $7.60 | 60 | — | 52.9% | $32.60 | $17.40 | 0 |
| Nov 20, 2026 | 22.50 | $6.48 | 60 | — | 52.9% | $28.98 | $16.03 | 0 |
| Jan 15, 2027 | 20.00 | $8.00 | 116 | — | 51.1% | $28.00 | $12.00 | 0 |
| Oct 16, 2026 | 22.50 | $5.35 | 25 | — | 42.0% | $27.85 | $17.15 | 0 |
| Apr 16, 2027 | 17.50 | $10.63 | 207 | — | 41.7% | $28.13 | $6.88 | 0 |
As of September 21, 2026
Find the right straddle before volatility moves
Track BBNX straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→